PacWest Financial Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,638
Closed -$1.53M 83
2016
Q3
$1.53M Sell
9,638
-380
-4% -$58.6K 0.94% 50
2016
Q2
$1.48M Buy
10,018
+140
+1% +$20.7K 0.92% 52
2016
Q1
$1.4M Sell
9,878
-255
-3% -$34.2K 0.9% 54
2015
Q4
$1.44M Sell
10,133
-435
-4% -$58K 0.96% 53
2015
Q3
$1.29M Buy
10,568
+115
+1% +$15K 0.95% 56
2015
Q2
$1.36M Buy
10,453
+145
+1% +$18.9K 0.95% 54
2015
Q1
$1.39M Buy
10,308
+75
+0.7% +$9.67K 0.98% 51
2014
Q4
$1.28M Sell
10,233
-40
-0.4% -$4.86K 0.91% 59
2014
Q3
$1.25M Buy
+10,273
New +$1.25M 0.93% 58

Other funds holding TMO

PacWest Financial Management's TMO Position: Q4 2016 in Review

PacWest Financial Management sold out of Thermo Fisher Scientific (TMO) in Q4 2016, closing a stake of 9,638 shares — an estimated $1.53M sold.

PacWest Financial Management first reported a position in TMO in Q3 2014 and held it in 9 quarters. The position peaked at $1.53M in Q3 2016. 1,114 funds tracked by Wall St. Rank hold TMO as of Q4 2016.

  • PacWest Financial Management reported no remaining Thermo Fisher Scientific position as of Q4 2016 after selling out during the quarter.
  • PacWest Financial Management sold 9,638 Thermo Fisher Scientific shares in Q4 2016, an estimated $1.53M.
  • PacWest Financial Management first reported a position in Thermo Fisher Scientific in Q3 2014 and held it in 9 quarters.
  • PacWest Financial Management's Thermo Fisher Scientific position peaked at $1.53M in Q3 2016.
  • 1,114 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.